Susquehanna International Group
ANIP icon

Susquehanna International Group’s ANI Pharmaceuticals ANIP Stock Holding History

Susquehanna International Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.16M Buy
54,114
+42,047
+348% +$3.28M ﹤0.01% 4587
2025
Q4 		$953K Buy
12,067
+2,095
+21% +$181K ﹤0.01% 7307
2025
Q3 		$913K Sell
9,972
-12,368
-55% -$1.01M ﹤0.01% 7561
2025
Q2 		$1.46M Sell
22,340
-25,721
-54% -$1.67M ﹤0.01% 6516
2025
Q1 		$3.22M Buy
48,061
+26,279
+121% +$1.57M ﹤0.01% 4514
2024
Q4 		$1.2M Buy
21,782
+7,795
+56% +$448K ﹤0.01% 6505
2024
Q3 		$834K Sell
13,987
-11,344
-45% -$692K ﹤0.01% 7237
2024
Q2 		$1.61M Sell
25,331
-25,190
-50% -$1.64M ﹤0.01% 5513
2024
Q1 		$3.49M Buy
50,521
+38,725
+328% +$2.34M ﹤0.01% 4225
2023
Q4 		$650K Buy
11,796
+8,177
+226% +$450K ﹤0.01% 8036
2023
Q3 		$210K Sell
3,619
-6,756
-65% -$390K ﹤0.01% 10125
2023
Q2 		$558K Sell
10,375
-2,438
-19% -$108K ﹤0.01% 8065
2023
Q1 		$509K Buy
+12,813
New +$540K ﹤0.01% 8524
2022
Q4 		– Sell
-16,465
Closed -$618K – 12321
2022
Q3 		$529K Sell
16,465
-534
-3% -$18.3K ﹤0.01% 8337
2022
Q2 		$504K Sell
16,999
-13,673
-45% -$394K ﹤0.01% 8236
2022
Q1 		$862K Buy
+30,672
New +$1.14M ﹤0.01% 7513
2021
Q4 		– Sell
-14,548
Closed -$625K – 13058
2021
Q3 		$477K Buy
14,548
+8,311
+133% +$258K ﹤0.01% 9505
2021
Q2 		$219K Buy
+6,237
New +$212K ﹤0.01% 11406
2020
Q4 		– Sell
-16,965
Closed -$486K – 10969
2020
Q3 		$479K Sell
16,965
-10,684
-39% -$318K ﹤0.01% 7773
2020
Q2 		$894K Sell
27,649
-1,137
-4% -$40.8K ﹤0.01% 6170
2020
Q1 		$1.17M Buy
28,786
+20,847
+263% +$1.11M ﹤0.01% 5034
2019
Q4 		$490K Sell
7,939
-29,115
-79% -$1.93M ﹤0.01% 7029
2019
Q3 		$2.7M Buy
37,054
+26,521
+252% +$1.98M ﹤0.01% 3676
2019
Q2 		$866K Buy
10,533
+4,576
+77% +$325K ﹤0.01% 6005
2019
Q1 		$420K Sell
5,957
-956
-14% -$56.2K ﹤0.01% 6602
2018
Q4 		$311K Buy
+6,913
New +$362K ﹤0.01% 6923
2017
Q4 		– Sell
-4,770
Closed -$297K – 9179
2017
Q3 		$250K Sell
4,770
-14,469
-75% -$690K ﹤0.01% 7684
2017
Q2 		$900K Buy
19,239
+4,088
+27% +$197K ﹤0.01% 5479
2017
Q1 		$750K Sell
15,151
-44,134
-74% -$2.48M ﹤0.01% 5739
2016
Q4 		$3.59M Buy
59,285
+7,677
+15% +$469K ﹤0.01% 2957
2016
Q3 		$3.42M Buy
51,608
+31,789
+160% +$1.99M ﹤0.01% 2722
2016
Q2 		$1.11M Sell
19,819
-85,061
-81% -$4.13M ﹤0.01% 4671
2016
Q1 		$3.53M Buy
104,880
+38,551
+58% +$1.31M ﹤0.01% 2799
2015
Q4 		$2.99M Buy
66,329
+26,106
+65% +$1.12M ﹤0.01% 3283
2015
Q3 		$1.59M Buy
+40,223
New +$2.29M ﹤0.01% 4736
2015
Q2 		– Sell
-4,801
Closed -$286K – 10067
2015
Q1 		$300K Sell
4,801
-1,789
-27% -$109K ﹤0.01% 7975
2014
Q4 		$372K Buy
+6,590
New +$291K ﹤0.01% 7771
2014
Q3 		– Sell
-18,244
Closed -$628K – 9380
2014
Q2 		$628K Sell
18,244
-6,082
-25% -$191K ﹤0.01% 7038
2014
Q1 		$763K Buy
+24,326
New +$646K ﹤0.01% 6001

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's ANIP Position: Q1 2026 in Review

Susquehanna International Group increased its ANI Pharmaceuticals (ANIP) stake by 348% in Q1 2026, buying an estimated $3.28M and bringing the position to 54,114 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4587.

Susquehanna International Group first reported a position in ANIP in Q1 2014 and has held it in 39 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Susquehanna International Group held 54,114 shares of ANI Pharmaceuticals worth $4.16M as of Q1 2026.
  • Susquehanna International Group bought 42,047 ANI Pharmaceuticals shares in Q1 2026, an estimated $3.28M.
  • ANI Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4587 holding.
  • Susquehanna International Group first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.